Personality disorders and substance abuse disorders. Psychosocial strategies;Trastornos de personalidad y conductas adictivas. Intervenciones psicosociales

Actas Espanolas de Psiquiatria

Volumn 29, Issue 1, 2001, Pages 58-66

  Lana Moliner, E ^a  

^a Centros Asistenciales Torribera   (Spain)

Author keywords

Comorbility; Dual disorders; Integrated treatment; Personality disorder; Substance abuse

Indexed keywords

ADDICTION; HEALTH CARE QUALITY; HUMAN; METHODOLOGY; PATIENT COMPLIANCE; PERSONALITY DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; PSYCHOTHERAPY; REVIEW;

DIAGNOSIS, DUAL (PSYCHIATRY); HUMANS; MODELS, PSYCHOLOGICAL; PATIENT COMPLIANCE; PERSONALITY DISORDERS; PROGRAM EVALUATION; PSYCHOTHERAPY; SUBSTANCE-RELATED DISORDERS;

EID: 0035221978     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Tyrer P. Cost-effective or profligate community psychiatry? Br J Psychiatry 1998;172:1-3.
2. Weaver T, Renton A, Stimson G, Tyrer P. Severe mental illness and substance misuse. BMJ 1999;318:137-8.
3. Caton CLM. The new chronic patient and the system of community care. Hosp Community Psychiatry 1981;32:475-8.
4. Regier DA, Farner ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbility of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990;264:2511-8.
5. Quirk SW, McCormick RA. Personality subtypes, coping styles, symptom correlates, and substances of choice among a cohort of substance abusers. Assessment 1998;5:157-69.
6. Ball SA, Tennen H, Poling JC, Kranzler HR, Rounsaville BJ. Personality, temperament, and character dimensions and the DSM-IV personality disorders in substance abusers. J Abnorm Psychol 1997;12:545-53.
7. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull 1998;24:589-608.
8. Ochoa Mangado E. Cocaína y comorbilidad psiquiátrica. Actas Esp Psiquiatría 2000;28:40-52.
9. Gastfriend DR. When a substance use disorder is the cause of treatment resistance. En: Pollack MH, Otto MW, Rosenbaum JF, eds. Challenges in clinical practice. Pharmacologic and psychosocial strategies. New York: Guilford Press; 1996. p. 329-54.
10. American Psychiatric Association. Directrices para la práctica clínica en el tratamiento de pacientes con trastornos por consumo de sustancias. Barcelona: Edika Med; 1997.
11. Caballero L. Relación médico-enfermo y psicoterapia en los trastornos de la personalidad. En: Bernardo M, Roca M. Trastornos de personalidad. Barcelona: Masson; 1998. p. 123-51.
12. Gottheil E, Weinstein SP, Sterling RC, Lundy A, Serota RD. A randomized controlled study of the effectiveness of intensive outpatient treatment for cocaine dependence. Psychiatr Serv 1998;49:782-7.
13. Ravndal E, Vaglum P. Psychopathology, treatment completion and 5 years outcome. A prospective study of drug abusers. J Subst Abuse Treat 1998;12:135-42.
14. Cacciola JS, Rutherford MJ, Alterman AI, McKay JR, Snider EC. Personality disorders and treatment outcome in methadone maintenance patients. J Nerv Ment Dis 1996;184:234-9.
15. Compton WM, Cottler LB, Spitznagel EL, Ben Abdallah A, Gallagher T. Cocaine users with antisocial personality improve HIV risk behaviors as much as those without antisocial personality. Drug Alcohol Depend 1998;49:239-47.
16. Synder CM, Kaempfer SH, Ries K. An interdisciplinary, interagency, primary care approach to case management of the dually diagnosed patient with HIV disease. J Assoc Nurses AIDS Care 1996;7:72-82.
17. Bernstein DP, Handelsman L. The neurobiology of substance and personality disorders. En: Ratey JJ, ed. Neuropsychiatry of personality disorders. Cambridge: Blackwell Science; 1995. p. 120-48.
18. Carrasco Perera JL. Neurobiología. En: Bernardo M, Roca M, eds. Trastornos de personalidad. Barcelona: Masson; 1998. p. 59-75.
19. Group for the Advancement of Psychiatry Committee. Substance abuse disorders: A psychiatric priority. Am J Psychiatry 1991;148:1291-9.
20. Woody GE, Luborsky L, McLellan AT, O'Brien CP, Beck AT, Blaine J, Herman I, Hole A. Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry 1983;40:639-45.
21. Horvath AO, Luborsky L. The role of the therapeutic alliance in psychotherapy. J Consult Clin Psychol 1993;61:561-73.
22. Jaffe JH. Substance-related disorders. Introduction and overview. En: Kaplan HI, Sadock B, eds. Comprehensive textbook of psychiatry/VI. Baltimore: Williams & Wilkins; 1995. p. 755-74.
23. Luborsky L, McLellan AT, Woody GE, O'Brien CP, Auerbach A. Therapist succes and its determinants. Arch Gen Psychiatry 1983;42:602-11.
24. Freixa N. Entrevistas motivacionales. Coloquios en drogodependencias 1999;7:8-9.
25. Fisher MS, Bentley KJ. Two group therapy models for clients with a dual diagnosis of substance abuse and personality disorder. Psychiatr Serv 1996;17:1244-50.
26. Penick EC, Nickel EJ, Cantrell PF, Powell BJ, Read Mr, Thomas MM. The emerging concept of dual diagnosis: An overview and implications. J Chem Dependency Treat 1990;3:1-54.
27. Conner KR, Silverstein SM, McCullock-Melnyk KA, Maxey JT. The development of a partial hospitalization program for mentally ill chemical abusing (MICA) patients. J Subst Abuse Treat 1995;12:311-8.
28. Meisler N, Blankertz L, Santos AB, McKay C. Impact of assertive community treatment on homeless persons with co-occurring severe psychiatric and substance use disorders. Community Ment Health J 1997;33:113-22.
29. Case N. The dual-diagnosis patient in a psychiatric day treatment program: A treatment failure. J Subst Abuse Treat 1991;8:69-73.
30. Kernberg O. Trastornos graves de la personalidad. México: El Manual Moderno; 1987.
31. Ridgely MS, Goldman HH, Wilenbring M. Barriers to the care of persons with dual diagnoses. Schizophr Bull 1990;16:123-32.
32. Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo J. Integrated treatment for dually diagnosed homeless adults. J Nerv Ment Dis 1997;185:289-305.
33. Strupp HH, Binder JL. Una nueva perspectiva en psicoterapia: Desclée de Brouwer. Bilbao; 1993.
34. Battaglia M, Przybeck TR, Bellodi L, Cloninger CR. Treatment dimensions explain the comorbility of psychiatric disorders. Compr Psychiatry 1996;12:292-8.
35. Howard MO, Kivlahan D, Walker RD. Cloninger's tridimensional theory of personality and psychopathology: applications to substance use disorders. J Stud Alcohol 1997;58:48-66.
36. Donovan JM, Soldz S, Kelley HF, Penk WE. Four addictions: the MMPI and discriminant function analysis. J Addict Dis 1998;17:41-55.
37. Pereda M, Ayuso-Mateos JL, Gomez del Barrio A, Echevarria S, Fariñas CM, Garcia Palomo D, González Macías J. Datos normativos para la exploración neuropsicológica de usuarios de drogas por vía parenteral. Actas Españolas de Psiquiatría 1998;26:363-70.
38. Miller L. Predicting relapse and recovery in alcoholism and addiction: neuropsychology, personality, and cognitive style. J Subst Abuse Treat 1991;8:277-91.
39. Wright FD, Beck AT, Newman CF, Liese BS. Cognitive therapy of substance abuse: theoretical rationale. NIDA Res Monogr 1993;137:123-46.
40. Bartels SJ, Drake RE, Wallach MA. Long-term course of substance use disorders among patients with severe mental illness. Psychiatr Serv 1995;46:248-51.
41. Links PS. Development effective services for patients with personality disorders. Can J Psychiatry 1998;12:251-159.
42. Ley A, Jeffery DP, McLaren S, Siegfried N. Treatment programmes for people with both severe mental illness and substance misure. The Cochrane Library. Oxford; 2000.